市場調查報告書
商品編碼
1387409
In Silico藥物研發市場報告:2030 年趨勢、預測與競爭分析In-Silico Drug Discovery Market Report: Trends, Forecast and Competitive Analysis to 2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
In Silico藥物研發的趨勢和預測
到 2030 年,全球In Silico藥物研發市場預計將達到 54.5 億美元,2024 年至 2030 年年複合成長率為 10.2%。該市場的主要促進因素是擴大關注減少用藥錯誤、在藥物研發中擴大採用雲端基礎的應用程式以及計算生物學的持續進步。全球In Silico藥物研發市場的未來前景廣闊,CRO、製藥業和學術/研究機構市場存在商機。
In Silico藥物研發市場洞察
Lucintel 預測,由於藥物研發過程中擴大採用虛擬篩選和目標發現,軟體即服務預計將在預測期內實現最高成長。
製藥業仍將是該市場中最大的部分,因為In Silico藥物研發有助於製藥公司縮短開發新藥的時間和成本。
由於生物製藥公司研發支出增加、大型製藥企業的存在以及大量患有各種慢性和感染疾病的患者,北美在預測期內將繼續成為最大的地區。
In-Silico Drug Discovery Trends and Forecast
The future of the global in-silico drug discovery market looks promising with opportunities in the contract research organizations, pharmaceutical industry, and academic & research institutes markets. The global in-silico drug discovery market is expected to reach an estimated $5.45 billion by 2030 with a CAGR of 10.2% from 2024 to 2030. The major drivers for this market are rising focus towards reduction of medication errors, increasing adoption of cloud-based applications in drug discovery, and on-going advancements in computational biology.
A more than 150-page report is developed to help in your business decisions.
In-Silico Drug Discovery by Segment
The study includes a forecast for the global in-silico drug discovery by type, target therapeutic area, workflow, end use, and region.
In-Silico Drug Discovery Market by Type [Shipment Analysis by Value from 2018 to 2030]:
In-Silico Drug Discovery Market by Target Therapeutic Area [Shipment Analysis by Value from 2018 to 2030]:
In-Silico Drug Discovery Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:
In-Silico Drug Discovery Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
In-Silico Drug Discovery Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of In-Silico Drug Discovery Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies in-silico drug discovery companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the in-silico drug discovery companies profiled in this report include-
In-Silico Drug Discovery Market Insights
Lucintel forecasts that software as a service is expected to witness the highest growth over the forecast period due to its increasing adoption for virtual screening and target fising in the drug discovery procedure.
Within this market, pharmaceutical industry will remain the largest segment due as in-silico drug discovery helps the pharmaceutical companies to reduce the time and cost of developing new drugs.
North America will remain the largest region over the forecast period due to increasing R&D expenditure by biopharma company, strong presence of marlet players, and large patient population suffering from various chronic and infectious diseases in the region.
Features of the Global In-Silico Drug Discovery Market
Market Size Estimates: In-silico drug discovery market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: In-silico drug discovery market size by various segments, such as by type, target therapeutic area, workflow, end use, and region in terms of value ($B).
Regional Analysis: In-silico drug discovery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, target therapeutic areas, workflow, end uses, and regions for the in-silico drug discovery market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the in-silico drug discovery market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the in-silico drug discovery market size?
Answer: The global in-silico drug discovery market is expected to reach an estimated $5.45 billion by 2030.
Q2. What is the growth forecast for in-silico drug discovery market?
Answer: The global in-silico drug discovery market is expected to grow with a CAGR of 10.2% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the in-silico drug discovery market?
Answer: The major drivers for this market are rising focus towards reduction of medication errors, increasing adoption of cloud-based applications in drug discovery, and on-going advancements in computational biology.
Q4. What are the major segments for in-silico drug discovery market?
Answer: The future of the in-silico drug discovery market looks promising with opportunities in the contract research organizations, pharmaceutical industry, and academic & research institutes markets.
Q5. Who are the key in-silico drug discovery market companies?
Answer: Some of the key in-silico drug discovery companies are as follows:
Q6. Which in-silico drug discovery market segment will be the largest in future?
Answer: Lucintel forecasts that software as a service is expected to witness the highest growth over the forecast period due to its increasing adoption for virtual screening and target fising in the drug discovery procedure.
Q7. In in-silico drug discovery market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to increasing R&D expenditure by biopharma company, strong presence of marlet players, and large patient population suffering from various chronic and infectious diseases in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.